Idenix
Idenix Pharmaceuticals is engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases.
Business Model:
Revenue: $469k
Employees: 51-200
Rankings
Industries / Tags:
Detailed Idenix Information
Idenix was acquired by
Merck Sharp &a; Dohme Sweden AB.
The acquisition happend on 2014-06-09.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 320 Bent St
City: Cambridge
State: MA
Zip: 02141
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$107M
Raised Total:$81M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Idenix Pharmaceuticals is engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases.
Contact Phone:
+16179959800
Contact Email:
Idenix went public on 7/22/2004 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/22/2004
Ticker Symbol:
IDIX
IPO Price:
$14/share
Amount Raised:
$81M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2011 | Post-IPO Equity | $5M | 7/2004 | IPO | $81.2M | 11/2010 | Post-IPO Equity | 1 | $20M |
ViiV Healthcare ViiV Healthcare ViiV Healthcare ViiV Healthcare |
1/2014 | Post-IPO Equity | 1 | $107M |
The Baupost Group The Baupost Group The Baupost Group The Baupost Group |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
